SCHEMBL7947382

SCHEMBL7947382

N#CCc1cccc(-c2ccc3c(c2)OCO3)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 1/20 0.56
PIK3CA P42336 1/20 0.49
PIK3CG P48736 1/20 0.49
MAPT P10636 2/20 0.46
PDCD1 Q15116 1/20 0.46
CD274 Q9NZQ7 1/20 0.46
TSHR P16473 1/20 0.46
GSK3A P49840 2/20 0.46
GSK3B P49841 2/20 0.46
PTPRC P08575 1/20 0.46
ADORA1 P30542 4/20 0.44
ADORA2A P29274 3/20 0.44
ADORA2B P29275 3/20 0.44
CALM1 P0DP23 1/20 0.43
PTGS2 P35354 1/20 0.43
NAAA Q02083 1/20 0.43
FYN P06241 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL141712 0.82 TAAR1 (0.55) MAPTTSHRCALM1ALDH1A1KMT2A
SCHEMBL29358232 0.82 TAAR1 (0.55) MAPTTSHRCALM1ALDH1A1KMT2A
SCHEMBL4009763 0.80 MMP3 (0.82) MMP3PIK3CAPIK3CGNAAAKDM4E
SCHEMBL4001097 0.80 MMP3 (0.82) MMP3PIK3CAPIK3CGNAAAKDM4E
SCHEMBL16675752 0.80 FYN (0.59) PDCD1CD274PTPRCCALM1PTGS2
SCHEMBL2929152 0.80 CALM1 (0.46) MAPTPDCD1CD274TSHRPTPRC
SCHEMBL18015825 0.80 MAPT (0.55) MAPTPTPRCCALM1PTGS2FYN
SCHEMBL2692579 0.78 CA12 (0.59) MAPTPTPRCADORA1ADORA2APTGS2
SCHEMBL4006124 0.78 MMP3 (0.72) MMP3PIK3CAPIK3CGGSK3BKDM4E
SCHEMBL29629010 0.78 PTGS2 (0.58) MAPTPTPRCADORA1ADORA2APTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329392-B1 ANTIALLERGENS AVENTIS PHARMACEUTICALS, INC. 2001-12-11 US disclosed
CN-1067385-C Novel substituted piperidines useful for the treatment of allergic diseases MERRELL DOW PHARMA (US) 2001-06-20 CN disclosed
EP-0777666-B1 SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMA INC (US) 1999-03-03 EP disclosed
US-5861416-A TREATMENT OF ASTHMA OR COUGH MERRELL PHARMACEUTICALS INC. (US) 1999-01-19 US disclosed
US-5824690-A TREATING ASTHMA, COUGH HOECHST MARION ROUSSEL INC. (US) 1998-10-20 US disclosed
EP-0696280-B1 SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES USEFUL AS TACHYKININ ANTAGONISTS MERRELL PHARMA INC (US) 1997-09-24 EP disclosed
CN-1158612-A Novel substituted piperidines for the treatment of allergic diseases MERRELL DOW PHARMA (US) 1997-09-03 CN disclosed
US-5661160-A ADMINISTERING AN ANTITUSSIVE AGENT FOR TREATING COUGH; TACHYKININ ANTAGONISM, SUBSTANCE P AND NEUROKININ A ANTAGONISM MERRELL PHARMACEUTICALS INC. (US) 1997-08-26 US disclosed
US-5648366-A TACHYKININ ANTAGONISTS USEFUL IN TREATING ASTHMA MERRELL PHARMACEUTICALS INC. (US) 1997-07-15 US disclosed
EP-0777666-A1 NOVEL SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMACEUTICALS INC. (US) 1997-06-11 EP disclosed
US-5635510-A TACHYKININ (ESPECIALLY SUBSTANCE P AND NEUROKININ A) ANTAGONISTS; ANTIINFLAMMATORY AGENTS, ANALGESICS; NERVOUS SYSTEM DISORDERS; BRONCHODILATOR AGENTS MERRELL PHARMACEUTICALS INC. (US) 1997-06-03 US disclosed
WO-1996006094-A1 NOVEL SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMACEUTICALS INC. (US) 1996-02-29 WO disclosed